Ani Pharmaceuticals (ANIP) EPS (Basic) Growth (3y) (2014 - 2026)
Ani Pharmaceuticals (ANIP) EPS (Basic) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 52.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.36% |
| Mar 31, 2026 | 181.79% |
| Dec 31, 2025 | 89.39% |
| Sep 30, 2025 | 63.48% |
| Jun 30, 2025 | 34.55% |
| Mar 31, 2025 | 37.72% |
| Dec 31, 2024 | 34.09% |
| Sep 30, 2024 | -51.07% |
| Jun 30, 2024 | 50.75% |
| Mar 31, 2024 | 416.92% |
| Dec 31, 2023 | 28.80% |
| Sep 30, 2023 | 135.59% |
| Jun 30, 2023 | 32.35% |
| Mar 31, 2023 | 28.20% |
| Dec 31, 2022 | 11.19% |
| Sep 30, 2022 | -54.46% |
| Jun 30, 2022 | -54.72% |
| Mar 31, 2022 | -228.02% |
| Dec 31, 2021 | -83.24% |
| Sep 30, 2021 | -41.84% |